Cargando…

Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis

BACKGROUND: The WHO Strategic Advisory Group of Experts recommended that an extended interval of 3–5 years between the two doses of the human papillomavirus (HPV) vaccine could be considered to alleviate vaccine supply shortages. However, three concerns have limited the introduction of extended sche...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bénard, Élodie, Drolet, Mélanie, Laprise, Jean-François, Jit, Mark, Prem, Kiesha, Boily, Marie-Claude, Brisson, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9764452/ https://www.ncbi.nlm.nih.gov/pubmed/36521952 http://dx.doi.org/10.1016/S2214-109X(22)00475-2

Ejemplares similares

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
por: Drolet, Mélanie, et al.
Publicado: (2021)

Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2023)

From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness
por: Jit, Mark, et al.
Publicado: (2021)

Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis
por: Prem, Kiesha, et al.
Publicado: (2023)

Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model
por: Jit, Mark, et al.
Publicado: (2015)

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Brisson, Marc, et al.
Publicado: (2020)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
por: Canfell, Karen, et al.
Publicado: (2020)

Now or later: Health impacts of delaying single‐dose HPV vaccine implementation in a high‐burden setting
por: Burger, Emily A., et al.
Publicado: (2022)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Mathematical Modeling of the Transmission Dynamics of Clostridium difficile Infection and Colonization in Healthcare Settings: A Systematic Review
por: Gingras, Guillaume, et al.
Publicado: (2016)

Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?
por: Drolet, Mélanie, et al.
Publicado: (2013)

Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules
por: Clark, Andrew, et al.
Publicado: (2019)

Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation
por: Fu, Han, et al.
Publicado: (2023)

Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta‐analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status
por: Looker, Katharine J, et al.
Publicado: (2018)

Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2018)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Projecting social contact matrices in 152 countries using contact surveys and demographic data
por: Prem, Kiesha, et al.
Publicado: (2017)

Screening for Human Papillomavirus in a Low- and Middle-Income Country
por: Atkinson, Aaron E., et al.
Publicado: (2019)

Potential lives saved in 73 countries by adopting multi‐cohort vaccination of 9–14‐year‐old girls against human papillomavirus
por: Jit, Mark, et al.
Publicado: (2018)

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts
por: Jit, Mark, et al.
Publicado: (2013)

Low Human Papillomavirus Vaccination in a Low-Income Urban Population
por: Rojo, Elizabeth M., et al.
Publicado: (2023)

Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis
por: Portnoy, Allison, et al.
Publicado: (2019)

Development of a brief assessment and algorithm for ascertaining dementia in low-income and middle-income countries: the 10/66 short dementia diagnostic schedule
por: Stewart, Robert, et al.
Publicado: (2016)

Food (In)Security in Rapidly Urbanising, Low-Income Contexts
por: Tacoli, Cecilia
Publicado: (2017)

Income security and infant health: Social context matters
por: Assari, Shervin, et al.
Publicado: (2022)

Platinum Growing Scarce
Publicado: (1889)

What works for human papillomavirus vaccine introduction in low and middle-income countries?
por: Howard, Natasha, et al.
Publicado: (2017)

Availability and affordability of medicines and cardiovascular outcomes in 21 high-income, middle-income and low-income countries
por: Chow, Clara Kayei, et al.
Publicado: (2020)

Rethinking health systems in the context of urbanisation: challenges from four rapidly urbanising low-income and middle-income countries
por: Elsey, Helen, et al.
Publicado: (2019)

Practical Use of Regularization in Individualizing a Mathematical Model of Cardiovascular Hemodynamics Using Scarce Data
por: Tivay, Ali, et al.
Publicado: (2020)

The relationship between income and assets in farms and context of sustainable development
por: Grzelak, Aleksander
Publicado: (2022)

Effects of disability on income and income composition
por: Pu, Christy, et al.
Publicado: (2023)

COVID-19 booster vaccination has not decreased access for low-income countries
por: Kalmar, C.L., et al.
Publicado: (2022)

Surfactant Administration Through Laryngeal or Supraglottic Airways (SALSA): A Viable Method for Low-Income and Middle-Income Countries
por: Zapata, Henry A., et al.
Publicado: (2022)

Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis
por: Dorji, Thinley, et al.
Publicado: (2021)

Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
por: Ebrahimi, Narges, et al.
Publicado: (2023)

Closing the Mind's Eye: Incoming Luminance Signals Disrupt Visual Imagery
por: Sherwood, Rachel, et al.
Publicado: (2010)

Disruption and selection: the income gradient in mortality among natives and migrants in Sweden
por: Östergren, Olof, et al.
Publicado: (2023)

The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
por: Portnoy, Allison, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r63g9iguv96nsfclvi99pg5i3c